TrialLancet (London, England)2018

Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial.

Adrian F Hernandez et al.PubMed ↗Publisher ↗

No numbers read from the abstract.